Human prostate and breast carcinoma cells undergo apoptosis when treated with various chemotherapeutic compounds, including camptothecins (CPT) [46] cisplatin [58] and taxol [39], [40] In addition, we have shown that RKIP is required for chemotherapy-triggered apoptosis [29]. This evidence concerns the gene PEBP1 and breast carcinoma.